[
  {
    "ts": "2026-01-29T12:00:00+00:00",
    "headline": "Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs",
    "summary": "TORONTO, January 29, 2026--Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (\"Satellos\" or the \"Company\"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced the appointment of Antoinette Paone as Chief Development Officer (\"CDO\") and Head of Regulatory Affairs. Ms. Paone brings extensive experience leading regulatory strategy from clinical development through approval, including her work on Kalydeco and Orkambi at",
    "url": "https://finance.yahoo.com/news/satellos-appoints-antoinette-paone-chief-120000268.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "c68f7375-0e80-358f-998e-c17fe8dfe2bb",
      "content": {
        "id": "c68f7375-0e80-358f-998e-c17fe8dfe2bb",
        "contentType": "STORY",
        "title": "Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs",
        "description": "",
        "summary": "TORONTO, January 29, 2026--Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (\"Satellos\" or the \"Company\"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced the appointment of Antoinette Paone as Chief Development Officer (\"CDO\") and Head of Regulatory Affairs. Ms. Paone brings extensive experience leading regulatory strategy from clinical development through approval, including her work on Kalydeco and Orkambi at",
        "pubDate": "2026-01-29T12:00:00Z",
        "displayTime": "2026-01-29T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/8517e436bf81071d9109b04c99a35bec",
          "originalWidth": 1301,
          "originalHeight": 302,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7KvzPNqU74cGoR_dPhKVBw--~B/aD0zMDI7dz0xMzAxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/8517e436bf81071d9109b04c99a35bec.cf.webp",
              "width": 1301,
              "height": 302,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mLfluk1k4K2RaiFTiwM5ZQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8517e436bf81071d9109b04c99a35bec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/satellos-appoints-antoinette-paone-chief-120000268.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/satellos-appoints-antoinette-paone-chief-120000268.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GBIO"
            },
            {
              "symbol": "MSCLF"
            },
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T14:20:00+00:00",
    "headline": "Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals",
    "summary": "The biotech could be on the verge of expanding its lineup and entering a new era of growth.",
    "url": "https://www.fool.com/investing/2026/01/29/prediction-2026-will-be-the-year-of-healthcare-sto/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "773e55c2-c9aa-3b53-b74d-81c1709101bb",
      "content": {
        "id": "773e55c2-c9aa-3b53-b74d-81c1709101bb",
        "contentType": "STORY",
        "title": "Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals",
        "description": "",
        "summary": "The biotech could be on the verge of expanding its lineup and entering a new era of growth.",
        "pubDate": "2026-01-29T14:20:00Z",
        "displayTime": "2026-01-29T14:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/2ce8d02368c14928d98f1679c1a7e9cd",
          "originalWidth": 1400,
          "originalHeight": 738,
          "caption": "Person raising both fists in the air.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/u9h0gTWHULOW94a.fEqIdQ--~B/aD03Mzg7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/2ce8d02368c14928d98f1679c1a7e9cd.cf.webp",
              "width": 1400,
              "height": 738,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/K5dsZwa.n296tJnKOnRbjg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/2ce8d02368c14928d98f1679c1a7e9cd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/29/prediction-2026-will-be-the-year-of-healthcare-sto/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/prediction-2026-vertex-pharmaceuticals-142000459.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]